Evidence map›Paper›PMID 24010731›Full record

ArticleAmerican journal of respiratory and critical care medicine2013

Lung bone marrow-derived hematopoietic progenitor cells enhance pulmonary fibrosis.

Taku Nakashima, Tianju Liu, Hongfeng Yu, Lin Ding, Matthew Ullenbruch, Biao Hu, Zhe Wu, Hideyuki Oguro, Sem H Phan

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia.American journal of physiology. Lung cellular and molecular physiology · 2021
    Trial
  3. Liver Kinase B1 in CD11cAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Remember Me? The Bone Marrow in Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2019
    Article
  15. Article
  16. NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2018
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Taku Nakashima1 Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan; and.
Tianju Liu
Hongfeng Yu
Lin Ding
Matthew Ullenbruch
Biao Hu
Zhe Wu
Hideyuki Oguro
Sem H Phan
University of Michigan · USChildren's Medical Center · US

Funding

Translational control of the fibroblast phenotype in IPFP01HL091775 · NHLBI · UNIVERSITY OF MINNESOTA · PI HENKE, CRAIG A · 2009 to 2013
$8.3M
MYOFIBROBLASTS IN PULMONARY FIBROSISR01HL052285 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PHAN, SEM H · 1994 to 2017
$5.4M
Mechanisms of Pulmonary FibrosisR37HL028737 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PHAN, SEM H · 2001 to 2010
$3.0M
Novel telomerase expressing lung fibroblast phenotypeR01HL077297 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PHAN, SEM H · 2004 to 2012
$3.0M
Resistin-like molecules in pulmonary fibrosisR01HL112880 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PHAN, SEM H · 2013 to 2016
$2.0M
MECHANISMS OF PULMONARY FIBROSISR01HL028737 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PHAN, SEM H · 1986 to 2000
$227k
NHLBI NIH HHS HL028737NHLBI NIH HHS HL 052285NHLBI NIH HHS HL077297NHLBI NIH HHS HL091775NHLBI NIH HHS P01 HL091775NHLBI NIH HHS R01 HL028737NHLBI NIH HHS R01 HL052285NHLBI NIH HHS R01 HL077297NHLBI NIH HHS R01 HL112880NHLBI NIH HHS R37 HL028737
6 · The paper itself

Abstract

rationaleBone marrow (BM)-derived cells have been implicated in pulmonary fibrosis. However, their precise role in pathogenesis is incompletely understood.

objectivesTo elucidate roles of BM-derived cells in bleomycin-induced pulmonary fibrosis, and clarify their potential relationship to lung hematopoietic progenitor cells (LHPCs).

methodsGFP BM-chimera mice treated with or without bleomycin were used to assess the BM-derived cells. MEASUREMENTS AND MAIN

resultsGFP(+) cells in the chimera lung were found to be comprised of two distinct phenotypes: GFP(hi) and GFP(low) cells. The GFP(hi), but not GFP(low), population was significantly increased after bleomycin treatment. Flow-cytometric analysis and quantitative real-time polymerase chain reaction revealed that GFP(hi) cells exhibited phenotypic characteristics of CD11c(+) dendritic cells and macrophages. GFP(hi) cell conditioned media were chemotactic for fibroblasts obtained from fibrotic but not normal lung in vitro. Moreover, adoptive transfer of GFP(hi) cells exacerbated fibrosis in recipient mice, similar to that seen on adoptive transfer of BM-derived CD11c(+) cells from donor bleomycin-treated mice. Next, we evaluated the potential of LHPCs as the source of GFP(hi) cells. Isolation of LHPCs by flow sorting revealed enrichment in cKit(+)/Sca1(-)/Lin(-) cells, most of which were GFP(+) indicating their BM origin. The number of LHPCs increased rapidly after bleomycin treatment. Furthermore, stem cell factor induced LHPC proliferation, whereas granulocyte-macrophage-colony stimulating factor induced differentiation to GFP(hi) cells.

conclusionsBM-derived LHPCs with a novel phenotype could differentiate into GFP(hi) cells, which enhanced pulmonary fibrosis. Targeting this mobilized LHPCs might represent a novel therapeutic approach in chronic fibrotic lung diseases.

Indexed as

AnimalsBleomycinCells, CulturedChimeraDisease Models, AnimalFemaleHematopoietic Stem CellsLungMiceMice, Inbred C57BLMice, TransgenicPulmonary FibrosisBleomycin

Identifiers

PMID24010731
PMCPMC3826283
OpenAlexW2019521786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.